CALLIDITAS THERAPEUTICS AB's ticker is CALT and the CUSIP is 13124Q106. A total of 19 filers reported holding CALLIDITAS THERAPEUTICS AB in Q4 2021. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,309 | +15.3% | 1,167 | 0.0% | 0.00% | – |
| Q2 2023 | $18,484 | +370.3% | 1,167 | +611.6% | 0.00% | – |
| Q1 2023 | $3,930 | +31.0% | 164 | 0.0% | 0.00% | – |
| Q4 2022 | $3,000 | 0.0% | 164 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 164 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | 0.0% | 164 | +0.6% | 0.00% | – |
| Q1 2022 | $3,000 | -25.0% | 163 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | +33.3% | 163 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 163 | +45.5% | 0.00% | – |
| Q2 2021 | $3,000 | – | 112 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 550,000 | $13,200,000 | 1.69% |
| BVF INC/IL | 750,000 | $18,000,000 | 0.98% |
| Vivo Capital, LLC | 580,000 | $13,920,000 | 0.80% |
| Endurant Capital Management LP | 111,467 | $2,675,000 | 0.79% |
| Burrage Capital Management LLC | 11,034 | $265,000 | 0.21% |
| HHLR ADVISORS, LTD. | 350,000 | $8,400,000 | 0.06% |
| Point72 Asset Management, L.P. | 257,892 | $6,189,000 | 0.03% |
| TUDOR INVESTMENT CORP ET AL | 24,422 | $586,000 | 0.02% |
| Pentwater Capital Management LP | 61,084 | $1,466,000 | 0.02% |
| Orbimed Advisors | 17,696 | $425,000 | 0.01% |